Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1 Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study

机译：308 nm单色准分子光和局部性白癜风局部用0.1％他克莫司软膏联合使用的安全性和有效性：一项开放标签研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 The Journal of Clinical and Aesthetic Dermatology
作者
Swapnil Shah; Jagadish Sakhiya; Pranoti Deshpande; Dhruv Sakhiya; Arun C. Inamadar;
展开▼
作者单位

展开▼
年(卷),期 2020(13),2
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类皮肤病学与性病学;
关键词
Monochromatic excimer light; skin pigmentation; tacrolimus; vitiligo;

机译：单色准分子光;皮肤色素沉着;他克莫司;白光;

相似文献

外文文献
中文文献

1. Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study [J] . Swapnil Shah, Jagadish Sakhiya, Pranoti Deshpande, The Journal of Clinical and Aesthetic Dermatology . 2020,第2期

机译：308纳米单色准分子光和局部0.1％Tacrolimus软膏的组合的安全性和有效性在节段性白癜风中的软膏：开放标签研究
2. Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients [J] . Bae Jung Min, Yoo Hyun Ju, Kim Hyub, Journal of the American Academy of Dermatology . 2015,第1期

机译：308 nm准分子激光，他克莫司局部用药和短期全身性皮质类固醇激素联合治疗分段性白癜风：159例患者的回顾性研究
3. A prospective study comparing the safety and efficacy of combination of topical tacrolimus 0.1% and mometasone furoate 0.01% with topical tacrolimus 0.1% alone in vitiligo [J] . Febina C. Puthiyapurayil, Anuradha Mothalampet, Najeeba Riyaz International Journal of Basic & Clinical Pharmacology . 2017,第8期

机译：一项前瞻性研究比较了局部使用他克莫司0.1％和糠酸莫米他松0.01％与单独使用局部他克莫司0.1％在白癜风中联合使用的安全性和有效性
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients [O] . Lu-Mei Wang, Wan-Jiao Lu, Jing-Tao Yuan, -1

机译：皮肤镜用于评估他克莫司软膏加308 nm受激准分子激光联合治疗局部白癜风患者的疗效
7. A prospective study comparing the safety and efficacy of combination of topical tacrolimus 0.1 and mometasone furoate 0.01 with topical tacrolimus 0.1 alone in vitiligo [O] . Febina C. Puthiyapurayil, Anuradha Mothalampet, Najeeba Riyaz 2017

机译：一项前瞻性研究比较了局部立冠司0.1％和米多酮源于0.01％的安全性和疗效，在白癜风中单独使用局部躯体毒素0.1％

Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1 Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study

著录项

相似文献

相关主题

期刊订阅